Crohn's disease - infliximab (review) and adalimumab: committee meeting

Following on from the email update you received in March regarding the delay to the use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn's disease appraisal, we can now confirm that the first Appraisal Committee meeting for will be held on 20 August 2008.

You can expect a set of papers for consultation during September 2008.

We will keep you informed of if there are any other changes. If you have any queries, please contact me at or by phone: 020 7045 2243.

Yours sincerely,                                        

Eloise Saile

This page was last updated: 30 March 2010